HOWARD PIEN Pill Pitcher
Biotech firm Chiron has grown briskly in recent years, with last year's revenue up 14% over 2001's, to $1.3 billion. Yet its future looks uncertain; few of its new drugs are close to reaching market. So the firm, based in Emeryville, Calif., has made Pien, 45, its new CEO. Born in China and reared in the Bronx, Pien has run GlaxoSmithKline's international operations for two years and is expected to help Chiron extend its global reach. Analysts say his toughest task will be building up the product pipeline.
PAULINE RICHARDS Bermuda Bookkeeper
A mother of two and...
To continue reading:
or
Log-In
